| PERIOD ENDING | 28-Dec-08 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 890,234 | 780,517 | 716,886 | | Cost of Revenue | 742,706 | 693,266 | 625,995 | | | Gross Profit | 147,528 | 87,251 | 90,891 | | | Operating Expenses | | Research Development | 77,652 | 84,992 | 71,193 | | Selling General and Administrative | 108,348 | 128,258 | 96,852 | | Non Recurring | 332,063 | 163,239 | 49,093 | | Others | 9,508 | 11,033 | 9,592 | | | | Total Operating Expenses | 527,571 | 387,522 | 226,730 | | | | Operating Income or Loss | (380,043) | (300,271) | (135,839) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46,074 | (2,066) | 10,839 | | Earnings Before Interest And Taxes | (333,969) | (302,337) | (125,000) | | Interest Expense | 11,233 |
-
| 7,931 | | Income Before Tax | (345,202) | (302,337) | (132,931) | | Income Tax Expense | 3,462 | 7,198 | 4,615 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (348,664) | (309,535) | (137,546) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (21,357) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (348,664) | (309,535) | (158,903) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($348,664) | ($309,535) | ($158,903) |
|
1.48% Nasdaq 
Income Statement
